Red blood cell distribution width is associated with sarcopenia risk in early-stage non-small cell lung cancer

被引:1
|
作者
Jia, Qing-chun [1 ]
Qin, Ling [2 ]
Niu, Ye [1 ]
Liu, Le [1 ]
Liu, Ping-ping [1 ]
Miao, Shi-di [3 ]
Cui, Ming-ming [1 ]
Wang, Rui-tao [1 ]
机构
[1] Harbin Med Univ, Harbin Med Univ Canc Hosp, Dept Internal Med, 150 Haping ST, Harbin 150081, Heilongjiang, Peoples R China
[2] Harbin Med Univ, Harbin Med Univ Canc Hosp, Dept Pathol, Harbin 150081, Heilongjiang, Peoples R China
[3] Harbin Univ Sci & Technol, Sch Comp Sci & Technol, Harbin 150080, Heilongjiang, Peoples R China
关键词
Red blood cell distribution; Sarcopenia; Non-small cell lung cancer; Computed tomography; MARKERS; INFLAMMATION; MUSCLE;
D O I
10.1186/s12885-024-11864-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Sarcopenia has received increasing attention in non-small cell lung cancer (NSCLC). Red blood cell distribution width (RDW) is a significant component of the complete blood count and indicates the heterogeneity of erythrocyte volume. Little information is known about RDW in relation to sarcopenia in early-stage (IA-IIIA) NSCLC. The purpose of the present study was to investigate the association between RDW and sarcopenia risk in early-stage NSCLC patients.Methods This study included 378 patients with pathologically confirmed stage IA-IIIA NSCLC. Sarcopenia was defined by measuring the skeletal muscle index (SMI) at the eleventh thoracic vertebra level. The maximum Youden index on the receiver operating characteristic (ROC) curve was used to estimate the cutoff value for RDW to predict sarcopenia. Logistic regression analyses were carried out to assess the independent risk factors for sarcopenia in NSCLC.Results The ROC curve indicated that the best cutoff point for RDW to predict sarcopenia was 12.9 (sensitivity of 43.80% and specificity of 76.76%, respectively). Moreover, there were significant differences in hemoglobin (p < 0.001), comorbidities (p = 0.001), histological type (p = 0.002), and cancer stage (p = 0.032) between the high RDW and low RDW groups. Logistic regression analyses revealed that high RDW is an independent risk factor for sarcopenia in early-stage NSCLC.Conclusion RDW is associated with sarcopenia risk in early-stage NSCLC.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Red blood cell distribution width is associated with sarcopenia risk in early-stage non-small cell lung cancer
    Qing-chun Jia
    Ling Qin
    Ye Niu
    Le Liu
    Ping-ping Liu
    Shi-di Miao
    Ming-ming Cui
    Rui-tao Wang
    BMC Cancer, 24
  • [2] Significance of the red blood cell distribution width in resected pathological stage I non-small cell lung cancer
    Toyokawa, G.
    Shoji, F.
    Yamazaki, K.
    Shimokawa, M.
    Takeo, S.
    ANNALS OF ONCOLOGY, 2019, 30
  • [3] EARLY-STAGE NON-SMALL CELL LUNG CANCER STRATIFYING RECURRENCE RISK
    Saito, T.
    Kono, Y.
    Ueno, Y.
    Maru, N.
    Utsumi, T.
    Matsui, H.
    Taniguchi, Y.
    Hino, H.
    Tsuta, K.
    Honda, O.
    Murakawa, T.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S559 - S560
  • [4] Genomic profiling and metastatic risk in early-stage non-small cell lung cancer
    Fick, Cameron N.
    Dunne, Elizabeth G.
    Lankadasari, Manendra B.
    Mastrogiacomo, Brooke
    Asao, Tetsuhiko
    Vanstraelen, Stijn
    Liu, Yuan
    Sanchez-Vega, Francisco
    Jones, David R.
    JTCVS OPEN, 2023, 16 : 9 - 16
  • [5] Adjuvant Therapy in Early-Stage Non-Small Cell Lung Cancer
    Serke, Monika
    CONTROVERSIES IN TREATMENT OF LUNG CANCER, 2010, 42 : 135 - 144
  • [6] Adjuvant chemotherapy for early-stage non-small cell lung cancer
    Visbal, AL
    Leighl, NB
    Feld, R
    Shepherd, FA
    CHEST, 2005, 128 (04) : 2933 - 2943
  • [7] Neoadjuvant chemotherapy in early-stage non-small cell lung cancer
    Salva, Francesc
    Felip, Enriqueta
    TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (05) : 398 - 402
  • [8] Sublobar resections in early-stage non-small cell lung cancer
    Sahin, Murat
    Yenigun, Mustafa Bulent
    Kocaman, Gokhan
    Duman, Elif
    Sakalli, Mehmet Ali
    Ozkan, Murat
    Yuksel, Cabir
    Cangir, Ayten Kayl
    Kutlay, Hakan
    Akal, Murat
    Enon, Serkan
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 27 (03): : 367 - 373
  • [9] Adjuvant chemotherapy in early-stage non-small cell lung cancer
    Dômont, J
    Soria, JC
    Le Chevalier, T
    SEMINARS IN ONCOLOGY, 2005, 32 (03) : 279 - 283
  • [10] Outcomes of Veterans With Early-Stage Non-Small Cell Lung Cancer
    Barrera, D. Espinoza
    Okoli, S. O.
    Choa, J.
    Chansangavej, S.
    Becnel, D.
    Palomino, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207